Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00275704 · ClinicalTrials.gov registry record · Phase 2
Flaxseed for the Treatment of Hot Flashes
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00275704: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT00275704 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00275704, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
Flaxseed, a phytoestrogen, is a natural food supplement rich in plant ligands, which have a very weak estrogen effect. In this study, flaxseed is being evaluated in regard to its capacity to safely and effectively treat hot flashes. Specifically, this study seeks to determine if flaxseed will lower the number and severity of hot flashes and if women experience any side effects from taking flaxseed for this purpose.
Interventions
- DRUG Flaxseed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2005-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00275704
The ClinicalTrials.gov registry entry for NCT00275704 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flaxseed is the first listed.
NCT00275704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00275704 about?
NCT00275704 is a clinical study titled "Flaxseed for the Treatment of Hot Flashes". Flaxseed, a phytoestrogen, is a natural food supplement rich in plant ligands, which have a very weak estrogen effect. In this study, flaxseed is being evaluated in regard to its capacity to safely and effectively treat hot flashes. Specifically, this study seeks to determine if flaxseed will lower ...
What is the current status of trial NCT00275704?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2005-05.
What interventions are being tested in trial NCT00275704?
The interventions under investigation include: Flaxseed (DRUG).
Who is sponsoring clinical trial NCT00275704?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.